Who owns Aeglea Biotherapeutics?

Tip: Access positions for across all investors

Analyze quarterly positions in Aeglea Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Aeglea Biotherapeutics stock

Who bought or sold Aeglea Biotherapeutics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
OrbiMed Advisors 4.0M $28M 0% Jun 2021
Baker Bros. Advisors 3.4M $24M 0% Jun 2021
BlackRock 3.1M $22M -7% Jun 2021
Adage Capital Partners GP 3.0M $21M 3% Jun 2021
Bain Capital Life Sciences Investors 2.7M $19M 0% Jun 2021
Pictet Asset Management 2.5M $18M 1% Jun 2021
Suvretta Capital Management 2.2M $17M 3% Sep 2021
Vanguard Group 2.1M $15M -4% Jun 2021
Aisling Capital Management 1.7M $12M 0% Jun 2021
Nantahala Capital Management 1.7M $12M -2% Jun 2021
Rock Springs Capital Management 1.6M $11M 0% Jun 2021

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Aeglea Biotherapeutics?

Artal Group 1.0M $7.3M 0% Jun 2021
Dr. Jeffrey R. Jay, M.D. 900k $6.3M 79% Jun 2021
Samsara BioCapital 884k $6.2M 0% Jun 2021
State Street Corporation 758k $5.3M 5% Jun 2021
Geode Capital Management 678k $4.7M 3% Jun 2021
Marshall Wace 651k $4.5M -45% Jun 2021
Dimensional Fund Advisors 633k $5.0M 5% Sep 2021
Altium Capital Management 610k $4.8M 0% Sep 2021
Boxer Capital 550k $3.8M 0% Jun 2021
Millennium Management 543k $3.8M 46% Jun 2021
Point72 Asset Management 470k $3.3M -69% Jun 2021
Axa 424k $3.0M 0% Jun 2021
Sio Capital Management 403k $2.8M 0% Jun 2021
Northern Trust 368k $2.6M -18% Jun 2021
Lion Point Capital 300k $2.1M 0% Jun 2021
Assenagon Asset Management 282k $2.0M 91% Jun 2021
University of Texas Investment Management Company 270k $1.9M -4% Jun 2021
Abingworth 241k $1.7M 0% Jun 2021
Morgan Stanley 196k $936k 100% Jun 2021
Nuveen Asset Management 180k $1.3M -3% Sep 2021
Comprehensive Portfolio Management 175k $1.2M 0% Jun 2021
Bank of New York Mellon 160k $1.3M 8% Sep 2021
Yu Fan 112k $780k 0% Jun 2021
Charles Schwab Investment Management 106k $737k -5% Jun 2021
Franklin Street Advisors 104k $824k 0% Sep 2021
Renaissance Technologies 100k $797k 97% Sep 2021
Jacobs Levy Equity Management 59k $413k -69% Jun 2021
California State Teachers Retirement System 56k $389k -18% Jun 2021
Rhumbline Advisers 53k $367k 14% Jun 2021
William Blair $ Company 52k $363k 0% Jun 2021
UBS Group 52k $363k 4% Jun 2021
D. E. Shaw & Co 46k $320k -27% Jun 2021
Algert Coldiron Investors 42k $289k -38% Jun 2021
Citadel Advisors 39k $272k -8% Jun 2021
Ergoteles 34k $237k 100% Jun 2021
Parametric Portfolio Associates 33k $231k 25% Jun 2021
SG Americas Securities 29k $227k 100% Sep 2021
Alliancebernstein 26k $178k 9% Jun 2021
Manufacturers Life Insurance Company 25k $201k -5% Sep 2021
Deutsche Bank Aktiengesellschaft 23k $185k -3% Sep 2021
American International 22k $176k -2% Sep 2021
CalPERS 21k $145k -76% Jun 2021
Bank of America Corporation 20k $141k -49% Jun 2021
Ing Investment Management 20k $138k -8% Jun 2021
New York State Common Retirement Fund 17k $136k -46% Sep 2021
ProShare Advisors 16k $124k -19% Sep 2021
Invesco 13k $90k 100% Jun 2021
Cubist Systematic Strategies 12k $82k -34% Jun 2021
GSA Capital Partners 11k $89k 100% Sep 2021
Personal Cfo Solutions 11k $87k -4% Sep 2021
Bnp Paribas Arbitrage, Snc 11k $86k 129% Sep 2021
Barclays 5.7k $40k -85% Jun 2021
IFP Advisors 4.0k $27k 14% Jun 2021
Summit Investment Advisors 3.7k $26k 0% Jun 2021
Legal & General Group 3.3k $23k -32% Jun 2021
Tower Research Capital 3.0k $21k 14% Jun 2021
Russell Investments 3.0k $23k -87% Sep 2021
Royal Bank of Canada 3.0k $15k -25% Jun 2021
Wells Fargo & Company 2.2k $25k -81% Jun 2021
O'shaughnessy Asset Management 1.7k $12k 0% Jun 2021
Quadrant Capital 1.1k $8.0k 0% Jun 2021
Penserra Capital Management 1.1k $7.0k 2% Jun 2021
Ellevest 150.00 $1.0k 33% Jun 2021
Daiwa Securities Group 98.00 $1.0k 0% Sep 2021
Berman Capital Advisors 56.00 $0 100% Sep 2021

Who sold out of Aeglea Biotherapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Driehaus Capital Management Mar 2021 175k $1.4M
Two Sigma Advisers Mar 2021 34k $268k
MetLife Investment Advisors Mar 2021 20k $161k
Two Sigma Investments Mar 2021 18k $145k
HPM Partners Jun 2021 18k $125k
Engineers Gate Manager Mar 2021 11k $86k
FNY Investment Advisers Mar 2021 1.5k $11k
Group One Trading Jun 2021 300.00 $2.0k